Trial · NCT00262821
Adverse events642
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 642
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergy/Immunology - Other | Immune system disorders | Concurrent Cisplatin and Radiation | 0 | 190 | |
| other | Allergy/Immunology - Other | Immune system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 1 | 180 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Concurrent Cisplatin and Radiation | 4 | 190 | |
| other | Allergic Reaction/Hypersensitivity | Immune system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 6 | 180 | |
| other | Rhinitis | Immune system disorders | Concurrent Cisplatin and Radiation | 3 | 190 | |
| other | Rhinitis | Immune system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 4 | 180 | |
| other | Auditory/Ear - Other | Ear and labyrinth disorders | Concurrent Cisplatin and Radiation | 3 | 190 | |
| other | Auditory/Ear - Other | Ear and labyrinth disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 2 | 180 | |
| other | Hearing (Without Monitoring Program) | Ear and labyrinth disorders | Concurrent Cisplatin and Radiation | 1 | 190 | |
| other | Hearing (Without Monitoring Program) | Ear and labyrinth disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 4 | 180 | |
| other | Tinnitus | Ear and labyrinth disorders | Concurrent Cisplatin and Radiation | 22 | 190 | |
| other | Tinnitus | Ear and labyrinth disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 25 | 180 | |
| other | Hearing (Monitoring Program) | Ear and labyrinth disorders | Concurrent Cisplatin and Radiation | 2 | 190 | |
| other | Hearing (Monitoring Program) | Ear and labyrinth disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 0 | 180 | |
| other | Neutrophils | Blood and lymphatic system disorders | Concurrent Cisplatin and Radiation | 86 | 190 | |
| other | Neutrophils | Blood and lymphatic system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 78 | 180 | |
| other | Platelets | Blood and lymphatic system disorders | Concurrent Cisplatin and Radiation | 73 | 190 | |
| other | Platelets | Blood and lymphatic system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 66 | 180 | |
| other | Blood/Bone Marrow - Other | Blood and lymphatic system disorders | Concurrent Cisplatin and Radiation | 6 | 190 | |
| other | Blood/Bone Marrow - Other | Blood and lymphatic system disorders | Concurrent Cisplatin, Tirapazamine and Radiation | 6 | 180 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00262821/events